These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29479865)

  • 1. Error in Percent Increased SRI-6 Response Rate in Subgroup of Atacicept-Treated Patients Versus Placebo in the Article by Merrill et al (Arthritis Rheumatol, February 2018).
    Arthritis Rheumatol; 2018 Mar; 70(3):467. PubMed ID: 29479865
    [No Abstract]   [Full Text] [Related]  

  • 2. Incorrect Versions of Supplementary Tables 4 and 5 and Errors in Safety Data and in Table 1 in the Article by Merrill et al (Arthritis Rheumatol, February 2018).
    Arthritis Rheumatol; 2021 Nov; 73(11):2043. PubMed ID: 34731536
    [No Abstract]   [Full Text] [Related]  

  • 3. Error in Figure 2B of the Article by Kolasinski et al (Arthritis Rheumatol, February 2020).
    Arthritis Rheumatol; 2021 May; 73(5):799. PubMed ID: 33913629
    [No Abstract]   [Full Text] [Related]  

  • 4. Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase II, randomized, placebo-controlled trial.
    van Vollenhoven RF; Kinnman N; Vincent E; Wax S; Bathon J
    Arthritis Rheum; 2011 Jul; 63(7):1782-92. PubMed ID: 21452294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Errors in Listing of Author's Institutional Affiliations in the Article by Eder et al (Arthritis Rheumatol, March 2017) and the Article by Polachek et al (Arthritis Rheumatol, May 2018).
    Arthritis Rheumatol; 2019 Apr; 71(4):625. PubMed ID: 30919594
    [No Abstract]   [Full Text] [Related]  

  • 6. Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial.
    Genovese MC; Kinnman N; de La Bourdonnaye G; Pena Rossi C; Tak PP
    Arthritis Rheum; 2011 Jul; 63(7):1793-803. PubMed ID: 21452293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of atacicept in combination with rituximab for reducing the signs and symptoms of rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled pilot trial.
    van Vollenhoven RF; Wax S; Li Y; Tak PP
    Arthritis Rheumatol; 2015 Nov; 67(11):2828-36. PubMed ID: 26137975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Middle Initial Omitted From Author Name in the Article by Felson et al (Arthritis Rheumatol, February 2017).
    Arthritis Rheumatol; 2017 Apr; 69(4):862. PubMed ID: 28371559
    [No Abstract]   [Full Text] [Related]  

  • 9. Author's Institutional Affiliation Omitted in the Article by Aeschlimann et al (Arthritis Rheumatol, February 2019).
    Arthritis Rheumatol; 2020 Jun; 72(6):1035. PubMed ID: 32460426
    [No Abstract]   [Full Text] [Related]  

  • 10. Error in Spelling of Author Name in the Article by Fang et al (Arthritis Rheumatol, August 2016).
    Arthritis Rheumatol; 2017 Nov; 69(11):2246. PubMed ID: 29077277
    [No Abstract]   [Full Text] [Related]  

  • 11. Atacicept as an investigated therapy for rheumatoid arthritis.
    Richez C; Truchetet ME; Schaeverbeke T; Bannwarth B
    Expert Opin Investig Drugs; 2014 Sep; 23(9):1285-94. PubMed ID: 25078871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Error in Description of Lesinurad Prescribing Information in the Article by Saag et al (Arthritis Rheumatol, January 2017).
    Arthritis Rheumatol; 2018 Aug; 70(8):1318. PubMed ID: 30134053
    [No Abstract]   [Full Text] [Related]  

  • 13. Error in Optimized Calcium Dosage Shown in Table 2 of the Article by Buckley et al (Arthritis Rheumatol, August 2017).
    Arthritis Rheumatol; 2017 Nov; 69(11):2246. PubMed ID: 29077279
    [No Abstract]   [Full Text] [Related]  

  • 14. Error in Description of Enzyme Range Calculations in Footnote of Table 3 in the Article by Rider et al (Arthritis Rheumatol, May 2017).
    Arthritis Rheumatol; 2018 Mar; 70(3):467. PubMed ID: 29479864
    [No Abstract]   [Full Text] [Related]  

  • 15. Error in Grant Number in the Article by Kwon et al (Arthritis Rheumatol, May 2020).
    Arthritis Rheumatol; 2020 Sep; 72(9):1513. PubMed ID: 33448664
    [No Abstract]   [Full Text] [Related]  

  • 16. Error in Algorithms for Manual Calculation of Patient Myopathy Scores in the Article by Lundberg et al (Arthritis Rheumatol, December 2017).
    Arthritis Rheumatol; 2018 Sep; 70(9):1532. PubMed ID: 30156386
    [No Abstract]   [Full Text] [Related]  

  • 17. Error in Units of Measure on Figures in the Article by Li et al (Arthritis Rheumatol, July 2020).
    Arthritis Rheumatol; 2020 Dec; 72(12):2135. PubMed ID: 33459526
    [No Abstract]   [Full Text] [Related]  

  • 18. Error in Reported Baricitinib Dose in the Article by Meesilpavikkai et al (Arthritis Rheumatol, May 2019).
    Arthritis Rheumatol; 2020 Dec; 72(12):2135. PubMed ID: 33459524
    [No Abstract]   [Full Text] [Related]  

  • 19. Error in Statement on Carbonated Beverage Consumption in the Article by FitzGerald et al (Arthritis Rheumatol, June 2020).
    Arthritis Rheumatol; 2021 Mar; 73(3):413. PubMed ID: 33638303
    [No Abstract]   [Full Text] [Related]  

  • 20. Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study.
    Tak PP; Thurlings RM; Rossier C; Nestorov I; Dimic A; Mircetic V; Rischmueller M; Nasonov E; Shmidt E; Emery P; Munafo A
    Arthritis Rheum; 2008 Jan; 58(1):61-72. PubMed ID: 18163485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.